These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23391211)

  • 1. Allometric scaling and prediction of concentration-time profiles of coagulation factors in humans from animals.
    Mahmood I
    Xenobiotica; 2013 Sep; 43(9):774-9. PubMed ID: 23391211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scaling.
    Mahmood I
    Haemophilia; 2014 Jan; 20(1):32-8. PubMed ID: 23855969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of drug concentration-time data in humans from animals: a comparison of three methods.
    Mahmood I; Goteti K
    Xenobiotica; 2012 Aug; 42(8):756-65. PubMed ID: 22360447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of oral pharmacokinetics of cMet kinase inhibitors in humans: physiologically based pharmacokinetic model versus traditional one-compartment model.
    Yamazaki S; Skaptason J; Romero D; Vekich S; Jones HM; Tan W; Wilner KD; Koudriakova T
    Drug Metab Dispos; 2011 Mar; 39(3):383-93. PubMed ID: 21098644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of drug concentration-time profiles of therapeutic proteins in humans from animals.
    Mahmood I
    Xenobiotica; 2013 Feb; 43(2):153-60. PubMed ID: 22830981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
    Mahmood I
    Curr Drug Metab; 2016; 17(10):1006-1013. PubMed ID: 27903219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults.
    Mahmood I
    J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators.
    Mahmood I
    Haemophilia; 2009 Sep; 15(5):1109-17. PubMed ID: 19523109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
    Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor.
    Titze MI; Schaaf O; Hofmann MH; Sanderson MP; Zahn SK; Quant J; Lehr T
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):545-558. PubMed ID: 28243682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug concentration-time profiles in children from adults: an allometric approach.
    Mahmood I; Goteti K
    Am J Ther; 2015; 22(2):132-40. PubMed ID: 23676343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
    Richter WF; Gallati H; Schiller CD
    Drug Metab Dispos; 1999 Jan; 27(1):21-5. PubMed ID: 9884305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
    Sanwald-Ducray P; Dow J
    Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of minipigs for predicting human pharmacokinetics: Prediction of distribution volume and plasma clearance.
    Yoshimatsu H; Konno Y; Ishii K; Satsukawa M; Yamashita S
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):73-81. PubMed ID: 26776246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel model for prediction of human drug clearance by allometric scaling.
    Tang H; Mayersohn M
    Drug Metab Dispos; 2005 Sep; 33(9):1297-303. PubMed ID: 15958605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.